Incorporation of liver chemistry score in predicting survival of liver-involved advanced gastric cancer patients who received palliative chemotherapy

被引:4
|
作者
Feng, Ying [1 ]
Zhang, Cheng [1 ,2 ]
Wu, Zhijun [3 ]
Xu, Hui [1 ,2 ]
Zhang, Xiaopeng [4 ]
Feng, Chong [4 ]
Shao, Jingyi [1 ]
Xie, Minmin [1 ]
Yang, Yahui [1 ]
Zhang, Yi [1 ]
Ma, Tai [1 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, 218 Jixi Rd, Hefei 230022, Anhui, Peoples R China
[2] Anhui Prov Canc Inst, Anhui Prov Off Canc Prevent & Control, Hefei, Peoples R China
[3] Maanshan Municipal Peoples Hosp, Dept Oncol, Maanshan, Peoples R China
[4] Hefei Ctr Dis Control & Prevent, Dept Noncommunicable Dis & Hlth Educ, Hefei, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 03期
关键词
gastric cancer; liver function tests; liver metastasis; survival analysis; PHASE-III; PROGNOSTIC-FACTORS; FUNCTION TESTS; CISPLATIN; TRIAL; MODEL; MULTICENTER; S-1;
D O I
10.1002/cam4.5179
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Gastric cancer liver metastasis (GCLM) patients usually accompany by abnormal serum liver function tests (LFTs) more or less; however, the prognostic value of LFTs is not fully understood. This study aimed to develop a liver chemistry score (LCS) based on LFTs and incorporate it into prognosis determination for GCLM patients who received palliative chemotherapy. Methods Data were derived from hospitalized GCLM patients in two general hospitals in China. LCS was generated based on the results of LFTs by LASSO regression. Cutoff value of the score was determined by restricted cubic spline. The score was then incorporated into Cox regression analysis to construct a predictive nomogram; the model was then evaluated internally and externally by AUC of time-dependent receiver operating characteristic curves (ROC) and calibration curves. Results Three hundred and thirty-six and 72 patients were included in development and validation cohort, respectively. LASSO regression analysis in development cohort finally reached a two-parametric LCS calculated on AST and ALP levels as 0.03343515 x ln (AST, U/L) + 0.02687997 x ln (ALP, U/L), and 0.232 was set as optimal cutoff value. Patients in low (LCS < 0.232) or high (LCS >= 0.232) score group experienced different survival times; median OS was 13.54 (95% CI: 11.1-15.6) months in the low LCS group and 7.3 (6.6-9.3) months in the high LCS group (p < 0.001). A nomogram including LCS and other clinical parameters was constructed and showed superior performance than model not including LCS. AUC of 6-month ROC improved from 0.647 (95% CI: 0.584-0.711) to 0.699 (0.638-0.759) in internal validation, and 0.837 (0.734-0.940) to 0.875 (0.784-0.966) in external validation. Conclusions Liver chemistry score is useful in determining the prognosis of gastric cancer patients with liver metastasis and may be helpful to clinicians in decision-making.
引用
收藏
页码:2831 / 2841
页数:11
相关论文
共 50 条
  • [31] Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy
    Kim, Jong Gwang
    Ryoo, Baek-Yeol
    Park, Yeon Hee
    Kim, Bong-Seog
    Kim, Tae-You
    Im, Young-Hyuck
    Kang, Yoon-Koo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (02) : 301 - 307
  • [32] Control of Nausea Based on Risk Analysis in Patients with Esophageal and Gastric Cancer Who Received Cisplatin-based Chemotherapy
    Fujii, Hironori
    Iihara, Hirotoshi
    Kajikawa, Noriko
    Kobayashi, Ryo
    Suzuki, Akio
    Tanaka, Yoshihiro
    Yamaguchi, Kazuya
    Yoshida, Kazuhiro
    Itoh, Yoshinori
    ANTICANCER RESEARCH, 2017, 37 (12) : 6831 - 6837
  • [33] Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy
    Jong Gwang Kim
    Baek-Yeol Ryoo
    Yeon Hee Park
    Bong-Seog Kim
    Tae-You Kim
    Young-Hyuck Im
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 301 - 307
  • [34] Predicting Overall Survival for Patients Who Underwent Adjuvant Chemoradiotherapy for Gastric Cancer
    Yilmaz, Melek Tugce
    Hurmuz, Pervin
    Dag, Osman
    Yigit, Ecem
    Ozyure, Yasin
    Avci, Hanife
    Cengiz, Mustafa
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2174 - S2175
  • [35] Risk factor analysis and nomogram construction of postoperative complications for patients with locally advanced gastric cancer who received neoadjuvant immunotherapy and chemotherapy
    Cui, Hao
    Zhang, Sijin
    Sun, Linde
    Yuan, Zhen
    Xu, Qixuan
    Gao, Jingwang
    Chen, Lin
    Cui, Jianxin
    Wei, Bo
    FRONTIERS IN MEDICINE, 2024, 11
  • [36] Perioperative chemotherapy improves survival of patients with locally advanced diffuse gastric cancer
    Li, Ze-Feng
    Li, Zheng
    Zhang, Xiao-Jie
    Sun, Chong-Yuan
    Fei, He
    Du, Chun-Xia
    Guo, Chun-Guang
    Zhao, Dong-Bing
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (09):
  • [37] Response to Preoperative Chemotherapy Predicts Survival in Patients Undergoing Hepatectomy for Liver Metastases from Gastric and Esophageal Cancer
    Andreou, Andreas
    Vigano, Luca
    Zimmitti, Giuseppe
    Seehofer, Daniel
    Dreyer, Martin
    Pascher, Andreas
    Bahra, Marcus
    Schoening, Wenzel
    Schmitz, Volker
    Thuss-Patience, Peter C.
    Denecke, Timm
    Puhl, Gero
    Vauthey, Jean-Nicolas
    Neuhaus, Peter
    Capussotti, Lorenzo
    Pratschke, Johann
    Schmidt, Sven-Christian
    JOURNAL OF GASTROINTESTINAL SURGERY, 2014, 18 (11) : 1974 - 1986
  • [38] Response to Preoperative Chemotherapy Predicts Survival in Patients Undergoing Hepatectomy for Liver Metastases from Gastric and Esophageal Cancer
    Andreas Andreou
    Luca Viganò
    Giuseppe Zimmitti
    Daniel Seehofer
    Martin Dreyer
    Andreas Pascher
    Marcus Bahra
    Wenzel Schoening
    Volker Schmitz
    Peter C. Thuss-Patience
    Timm Denecke
    Gero Puhl
    Jean-Nicolas Vauthey
    Peter Neuhaus
    Lorenzo Capussotti
    Johann Pratschke
    Sven-Christian Schmidt
    Journal of Gastrointestinal Surgery, 2014, 18 : 1974 - 1986
  • [39] Association of sarcopenia with severe chemotherapy toxicities and survival in patients with advanced gastric cancer
    Chan, Wing-Lok
    Yun, Ho-Kwan Bryan
    Cheung, Emina Edith
    Liu, Michelle
    Hou, Li-Yu
    Lam, Ka-On
    Wong, Ian Yu-Hong
    Chiu, Wan-Hang Keith
    Law, Simon
    Kwong, Dora
    ONCOLOGIST, 2024, 29 (10) : e1272 - e1279
  • [40] Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil
    Matsunaga, Tomoyuki
    Saito, Hiroaki
    Miyauchi, Wataru
    Shishido, Yuji
    Miyatani, Kozo
    Morimoto, Masaki
    Murakami, Yuki
    Hanaki, Takehiko
    Kihara, Kyoichi
    Yamamoto, Manabu
    Tokuyasu, Naruo
    Takano, Shuichi
    Sakamoto, Teruhisa
    Hasegawa, Toshimichi
    Fujiwara, Yoshiyuki
    BMC CANCER, 2021, 21 (01)